Results 21 to 30 of about 21,407 (219)

Oral atenolol versus propranolol in the treatment of infantile hemangioma: A systematic review and meta-analysis

open access: yesJournal of Indian Association of Pediatric Surgeons, 2022
Background: Infantile hemangioma (IH) is the most common benign vascular tumor of infancy. Propranolol is considered first-line therapy for IH. However, it is associated with side effects. Therefore, there was a need for alternative therapy.
Swapnil Annasaheb Pattanshetti   +10 more
doaj   +1 more source

Atenolol Ameliorates Skeletal Muscle Atrophy and Oxidative Stress Induced by Cast Immobilization in Rats

open access: yesBiomedicines, 2023
(1) Background: Skeletal muscle atrophy is a common and debilitating condition associated with disease, bed rest, and inactivity. We aimed to investigate the effect of atenolol (ATN) on cast immobilization (IM)-induced skeletal muscle loss.
Anand Kumar   +8 more
doaj   +1 more source

A molecular inclusion complex of atenolol with 2-hydroxypropyl-b-cyclodextrin; the production and characterization thereof [PDF]

open access: yesJournal of the Serbian Chemical Society, 2007
The molecular inclusion complex of atenolol with 2-hydroxypropyl-b-cy­clodextrin was synthesized using the coprecipitation method. The complex obtained was characterized by FT-IR, 1H‑NMR, 13C-NMR spectroscopy, as well as by DSC and X-ray diffraction ...
VESNA NIKOLIC   +5 more
doaj  

FORMULASI SEDIAAN ORALLY DISINTEGRATING TABLET ATENOLOL DENGAN SODIUM STARCH GLYCOLATE SEBAGAI SUPERDISINTEGRAN

open access: yesJurnal Farmasi Sains dan Komunitas, 2017
Atenolol, a competitive beta (1)-selective adrenergic antagonists, has been widely used in hypertension therapy. Administration of conventional tablets of atenolol has limitation due to patient compliance in geriatric patients. Formulation of atenolol as
Karina Citra Rani   +2 more
doaj   +1 more source

Hepatotoxicity of atenolol therapy - A report of 2 cases

open access: yesJournal of Acute Disease, 2013
This case report highlights atenolol induced episodes of chronic and acute hepatotoxicities in 2 elderly hypertensive patients. The 1st patient manifested liver dysfunction after 8 months of 50 mg daily atenolol therapy and in the 2nd patient liver ...
Somnath Mondal   +6 more
doaj   +1 more source

Remote Modulation of Single‐Atom Catalyst Boosts High‐Valent Cobalt–Oxo Species Generation for Water Purification and Detoxification

open access: yesAdvanced Science, EarlyView.
This study develops a phosphorus‐doped cobalt single‐atom catalyst that enhances high‐valent cobalt–oxo species generation for water purification. This atomic‐level tuning boosts the catalyst's activity by 3.5 times, enabling efficient pollutant degradation. A continuous‐flow reactor achieves high, long‐term removal efficiency, producing water with low
Wen‐Min Wang   +4 more
wiley   +1 more source

Mechanistic Insights Into Photocatalytic Materials for Toxic Pollutants: Environmental Remediation of Personal Care Products

open access: yesAsia-Pacific Journal of Chemical Engineering, EarlyView.
ABSTRACT Photocatalytic materials have emerged as promising solutions for environmental applications due to their ability to degrade organic pollutants under sunlight or artificial light. In this review, recent progress on the photocatalytic materials used for the degradation of pharmaceutical personal care products (PPCPs) in environmental ...
Urvashi Sen   +5 more
wiley   +1 more source

Mucous membrane pemphigoid in a patient with hypertension treated with atenolol: a case report

open access: yesJournal of Medical Case Reports, 2012
Introduction Atenolol is commonly used by patients with hypertension, angina pectoris, or myocardial infarction. There have been reports of various adverse effects associated with the use of atenolol including bullous pemphigoid.
Kanjanabuch Patnarin   +3 more
doaj   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy